BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/1/2024 2:45:05 AM | Browse: 82 | Download: 88
|
Received |
|
2023-10-08 01:56 |
|
Peer-Review Started |
|
2023-10-08 01:58 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-04 00:36 |
|
Revised |
|
2024-01-02 02:50 |
|
Second Decision |
|
2024-02-05 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-02-05 06:56 |
|
Articles in Press |
|
2024-02-05 06:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-02-25 05:39 |
|
Publish the Manuscript Online |
|
2024-03-01 02:45 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Case Report |
Article Title |
Extended survival with metastatic pancreatic cancer under fruquintinib treatment after failed chemotherapy: Two case reports
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Dan Wu, Qiong Wang, Shuai Yan, Xia Sun, Ya Qin, Ming Yuan, Nan-Yao Wang and Xian-Ting Huang |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Wuxi Health and Health Committee |
MS201908 |
|
Corresponding Author |
Qiong Wang, MD, Chief Doctor, Professor, Department of Oncology, Jiangyin People's Hospital, No. 163, Shoushan Road, Wuxi 214400, Jiangsu Province, China. wangqiong55@hotmail.com |
Key Words |
Pancreatic cancer; Anti-vascular endothelial growth factor receptor; Fruquintinib; Case report |
Core Tip |
These two cases achieved a progress-free survival benefit from later-line single-agent fruquintinib therapy. With its better safety profile, fruquintinib may be worth exploring and studying in more depth as a later-line treatment for pancreatic cancer patients. This is the first literary report on Fruquintinib used in metastasis pancreatic cancers. |
Publish Date |
2024-03-01 02:45 |
Citation |
Wu D, Wang Q, Yan S, Sun X, Qin Y, Yuan M, Wang NY, Huang XT. Extended survival with metastatic pancreatic cancer under fruquintinib treatment after failed chemotherapy: Two case reports. World J Clin Cases 2024; 12(7): 1296-1304 |
URL |
https://www.wjgnet.com/2307-8960/full/v12/i7/1296.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v12.i7.1296 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345